1. Hot keywords:Tobramycin sulfate injection / bupivacaine hydrochloride injection / amlodipine besylate tablets / bupivacaine hydrochloride injection

            PRODUCTS

            產品展示

            PRODUCTS

            產品展示

            COOPERATIVE PARTNER

            COOPERATIVE PARTNER

            關于我們

            ABOUT US

            ABOUT US

            關于我們

            Anhui Changjiang Pharmaceutical Co., Ltd. is located in Wuhu, Anhui Province, which is a beautiful and rich "giant port of the Yangtze River and the backbone of Anhui Province". Wuhu is located in the northwest of the Yangtze River Delta, with superior geographical position, adjacent to the river and offshore, connecting the East with the west, connecting the South with the north, with convenient transportation and beautiful environment. Wuhu is also an important comprehensive transportation hub in China. Wuhu port, with the fifth largest port in the Yangtze River, is the larger foreign trade terminal in Anhui Province.
            Time of establishment: December 2001
            Registered address: No.152, Changjiang South Road, high tech Development Zone, Yijiang District, Wuhu City, Anhui Province

            Tel: 0553-2245066 (domestic sales) 0553-2245055 (export sales)

            Business Scope: Licensed Items: Pharmaceutical Production: Drug Entrusted Production: Class II Medical Device Production (Items subject to approval in accordance with the law can only carry out business activities after being approved by the relevant departments. The specific business projects are subject to the approval documents or licenses of the relevant departments. )
            General Items: Technology Import and Export: Goods Import and Export: Technical Services, Technology Development, Technology Consulting, Technology Exchange, Technology Transfer, Technology Promotion: Medical Research and Experimental Development: Engineering and Technology Research and Experimental Development (except for licensing business, which can be independently To operate projects that are not prohibited or restricted by laws and regulations)

            Registered capital: 70 million yuan

            ......

            NEWS

            NEWS

            The enterprise image of "science and technology dedication, true feelings, quality achievements and health" is the strategy to accelerate the development of enterprises

            DEVELOPMENT HISTORY

            DEVELOPMENT HISTORY

            • 1954
            • 2001
            • 2002
            • 2006
            • 2008
            • 2013
            • 2014
            • 2016
            • 2019

            Anhui Changjiang pharmaceutical factory (state-owned enterprise, established in 1954)

            The current director, Mr. Guilin, restructured and reorganized the company

            Three dosage forms of the company passed national GMP certification at one time

            The enterprise technology research center has been set up, and the foreign trade has obtained the independent export right

            Anhui Province "pharmaceutical production management, efficiency" double excellent "enterprises and national" high tech enterprises "

            The new version of GMP I was approved in March

            In March, Shuizhen II workshop passed the national new GMP certification

            In August, the solid workshop passed the national new GMP certification

            In July, the company was renamed Anhui Changjiang Pharmaceutical Co., Ltd

            MARKETING STRATEGY

            1. Protection of existing products and key products;
            2. We should use modern marketing concept to open up new product market and promote the whole marketing process of key products with humanistic concept;
            3. Increase the promotion of new drug varieties with market potential, and completely reverse the situation of lack of follow-up products and short product line;
            4、Actively seek multi-channel cooperation to increase the market competitiveness and added value of traditional varieties;

            BUSINESS SITUATION

            Domestic market accounts for 60% 

            At present, 24 provinces and cities in China have established sales networks and participated in bidding, and the products have been sold by pharmaceutical companies. Among them, East China and central China are the main markets

            Export 30%

            It has been registered in more than 20 overseas countries and regions, mainly to Eastern Europe, South America, Africa, the Middle East and Southeast Asia

            Cooperative production 10%

            It has successively cooperated with well-known domestic pharmaceutical enterprises, including Shanghai Pharmaceutical Group, China Resources medicine, JIUZHOUTONG Pharmaceutical Group, etc

            久久久久久久久精品中文字幕一区 好吊色欧美一区二区三区视频 成人免费无码H在线观看不卡 亚洲成AV人片一区二区米奇